WEDNESDAY, April 3, 2024 (HealthDay News) — A new test might allow some women with an aggressive form of breast cancer to skip chemotherapy without harm, researchers say. Women with early-stage triple-negative breast cancer appear to have better survival rates and a lower risk of recurrence if they carry highContinue Reading
THURSDAY, April 1, 2024 (HealthDay News) — In a letter sent to teaching hospitals and medical schools across the country, the U.S. Department of Health and Human Services said Monday that written consent must be obtained from patients before performing sensitive procedures such as pelvis and prostate exams. The agencyContinue Reading
THURSDAY, March 28, 2024 (HealthDay News) — Dr. Gary Gibbon didn’t have long to live. A harsh cocktail of chemotherapy, radiation and immunotherapy for his advanced lung cancer had permanently destroyed his lungs and caused irreparable damage to his liver. But Gibbon, a 69-year-old resident of Santa Monica, Calif., remainsContinue Reading
THURSDAY, March 28, 2024 (HealthDay News) — The contraceptive injection Depo-Provera and two drugs used for menopause relief could be linked to a heightened risk for brain tumors in some women, a new study warns. Depo-Provera (medroxyprogesterone acetate) increased the risk of intracranial meningioma 5.6-fold if used for longer thanContinue Reading
MONDAY, March 25, 2024 (HealthDay News) — Men with prostate cancer treated at hospitals participating in a special drug-pricing program were more likely to stick to their therapy than patients elsewhere, new research reveals. The federal 340B Drug Program requires the pharmaceutical industry to discount drugs sold to participating hospitalsContinue Reading
FRIDAY, March 22, 2024 (HealthDay News) — Catherine, Princess of Wales, announced Friday that she has been diagnosed with cancer and has begun chemotherapy treatments. The news, which she disclosed in a video released by Kensington Palace, came after days of speculation about her health. It follows the disclosure inContinue Reading
FRIDAY, March 22, 2024 (HealthDay News) — An already approved cancer drug could be an effective treatment for women with advanced, recurring uterine cancer, a new clinical trial shows. Rucaparib, which belongs to a class of drugs called PARP inhibitors, extended women’s survival for more than a year and aContinue Reading
THURSDAY, March 21, 2024 (HealthDay News) — A germ commonly found in the human mouth can travel to colon tumors and appears to speed their growth, new research shows. The finding might lead to new insights into fighting colon cancer, which kills more than 52,000 Americans each year, according toContinue Reading
WEDNESDAY, March 20, 2024 (HealthDay News) — Killing off large tumors by freezing them could become an effective means of fighting difficult-to-treat breast cancer, a new study says. Only 10% of people who underwent the minimally invasive procedure, called cryoablation, had their cancer come back within 16 months, researchers said.Continue Reading
WEDNESDAY, March 20, 2024 (HealthDay News) — Exercise can help women better cope with the rigors of advanced breast cancer, a new study says. Patients had less pain and fatigue, as well as an improved quality of life, after taking part in a regular exercise program, researchers reported today atContinue Reading
TUESDAY, March 19, 2024 (HealthDay News) — Artificial intelligence tools don’t always help radiologists better review a patient’s X-rays or CT scans, a new study claims. AI has been touted as a potential means of improving doctors’ ability to interpret medical images, the researchers said. However, the benefits of AIContinue Reading
MONDAY, March 18, 2024 (HealthDay News) — The last remnants of asbestos use in the United States have now been banned by the Environmental Protection Agency. While the known carcinogen has already been largely banned, the EPA announced Monday that it would ban the last remaining form of asbestos —Continue Reading
MONDAY, March 18, 2024 (HealthDay News) — High school students who use tobacco and cannabis products miss more school and have lower grades than classmates who use them individually or not at all. That’s the conclusion of a study by researchers at UC Davis Health. “Substance use is a mainContinue Reading
THURSDAY, March 14, 2024 (HealthDay News) — Delivering dual-targeted, immune-focused CAR T cancer therapy via a patient’s spinal fluid quickly shrank deadly brain tumors, researchers report. CAR T therapy harnesses the power of the patient’s immune system T-cells, which are reprogrammed to seek and destroy a specific protein found onContinue Reading